Recordati

REC

IT0003828271

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 07:43:53 2024-12-06 am EST			5-day change	1st Jan Change
51.35 ^EUR	-0.10%		-0.39%	+5.16%

Dec. 04	Mib lone in green; focus on French vote	AN
Dec. 03	Europeans in green, Korea tensions push Brent	AN

Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the Nine Months Ended September 30, 2024

November 08, 2024 at 06:15 am EST

Recordati Industria Chimica e Farmaceutica S.p.A. reported earnings results for the nine months ended September 30, 2024. For the nine months, the company reported sales was EUR 1,743.08 million compared to EUR 1,556.17 million a year ago. Net income was EUR 338.4 million compared to EUR 304.49 million a year ago.

Basic earnings per share from continuing operations was EUR 1.64 compared to EUR 1.481 a year ago. Diluted earnings per share from continuing operations was EUR 1.618 compared to EUR 1.456 a year ago.

Latest news about Recordati

Mib lone in green; focus on French vote	Dec. 04	AN
Europeans in green, Korea tensions push Brent	Dec. 03	AN
Italian stock market maglia rosa; Mib at 33,900	Dec. 03	AN
Stock markets in the green; Amplifon leads the rises on the Mib.	Dec. 03	AN
Futures up slightly; focus on French crisis	Dec. 03	AN
Business Square in the green; up Nexi, down Stellantis	Dec. 02	AN
Stock markets contrast; down Italy unemployment	Dec. 02	AN
Bags in red pre-PMI; eyes on Stellantis	Dec. 02	AN
Recordati takes over Enjaymo and expects strong revenue boost	Nov. 29	AN
Recordati-Angelini, possible merger in pharmaceutical sector	Nov. 27	AN
Recordati investor CVC taps up potential buyers of drugs group, rival says	Nov. 26	RE
European indexes expected to be in positive territory	Nov. 25	AN
European stock exchanges in green; euro at two-year low	Nov. 22	AN
Only Terna up on Mib; down on banks	Nov. 19	AN
Mib in negative territory; bad banking sector	Nov. 19	AN
Trump makes Wall Street shine and depresses Europe	Nov. 11
Futures expect stock exchanges to rise markedly	Nov. 11	AN
Mib down, financial stocks weigh.	Nov. 08	AN
Italy's Recordati sees no impact from potential US pharma tariffs	Nov. 08	RE
Global markets live: Airbnb, Motorola, Blackrock, P&G, Leonardo...	Nov. 08
Recordati Industria Chimica e Farmaceutica S.p.A., Nine Months 2024 Earnings Call, Nov 08, 2024	Nov. 08
Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the Nine Months Ended September 30, 2024	Nov. 08	CI
Milan stock exchange starts sharply down on China, luxury heavy, down also oil, good Italgas	Oct. 08	RE
Lists bearish; widespread red on Wall Street	Oct. 08	AN
Mib advances to 33,800 area; Amplifon pulls away from all	Oct. 07	AN

Chart Recordati

Duration

Period

REC: Dynamic Chart

Company Profile

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (34.3%). Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).

Employees

4,455

Sector

Pharmaceuticals

Calendar

2025-01-08 - ODDO BHF Forum

More about the company